- Hims & Hers Health, Inc. stock plunged 14.73 % to close at $25.00 following a federal lawsuit filed by the FTC and co-plaintiffs on July 29, 2026.
- The lawsuit alleges deceptive health data sharing with third-party advertisers and subscription billing violations under the Restore Online Shoppers' Confidence Act.
- Shareholders rights firm Hagens Berman subsequently opened an investigation into the company's corporate compliance, internal controls, and financial reporting disclosures.
- Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by Hims & Hers Health, Inc. on behalf of injured investors.
- The investigation follows a July 29, 2026, FTC lawsuit accusing Hims & Hers of deceptively sharing sensitive patient medical information with third-party advertisers like Meta and Snap.
- Following the lawsuit announcement, Hims & Hers stock price dropped by over 14 %, prompting the law firm to invite affected investors to discuss their legal rights.
- Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by Hims & Hers Health, Inc. on behalf of investors.
- The investigation follows a Federal Trade Commission lawsuit filed on July 29, 2026, accusing Hims & Hers of deceptively sharing sensitive medical information with third-party advertisers like Meta and Snap.
- Following the lawsuit news, Hims & Hers stock dropped over 14 %, prompting the law firm to encourage affected investors to come forward.
- Benzinga's options scanner identified notable whale trading activity across 10 health care stocks during the session.
- The tracked transactions feature a mix of bullish and bearish call option trades and sweeps with varying expiration dates and strike prices.
- Notable activity includes ELV with a bullish trade totaling $564.0K and LQDA with a bullish sweep totaling $138.0K.